Introduction
============

Although the morbidity and mortality of gastric cancer (GC) have been decreased recent years globally, new cases and deaths from GC in China are still on a relatively high level, accounting for 42.6% new cases and 45% deaths from GC worldwide ([@ref-12]). As the development of medical science, GC patients have experienced longer survival ([@ref-2]). In China, five-year survival rate for GC increased from 27.4% in 2003 to 35.1% in 2015 ([@ref-23]).

Surgical resection is considered to be the only radical treatment for GC combined with neoadjuvant therapy or not. Body weight loss is a prevalent problem among patients after surgical treatment. A study in Japan followed up 105 patients with stage I GC undergoing open distal gastrectomy (ODG) or laparoscopy-assisted distal gastrectomy (LADG), and found that body weight loss at 1 week, 1 month, and 3 months were --3.0%, --4.9%, and --5.4%, respectively in patients who underwent ODG, while in those undergoing LADG, the body weight change was --2.7%, --4.3%, and --5.7%, respectively ([@ref-6]). Patients who were treated with neoadjuvant chemotherapy before gastrectomy experienced a nadir weight loss about 10%--15% at 6 months after surgery ([@ref-9]). In China, [@ref-10] found that body weight loss of GC patients reached the lowest within 3 months after gastrectomy.

Body weight loss has been associated with GC patient outcome. A more than 12% post-surgery body weight loss was strongly associated with poorer disease-free survival in GC ([@ref-15]). In addition, body weight loss has not only been related with GC patient postoperative survival, but also associated with poorer quality of life. A cohort study followed up 76 patients undergoing curative gastric cancer resection and surviving at least two years without recurrence to examine the quality of life, and the results showed that body weight loss 10% or greater was associated with deterioration of all functional aspects of quality of life, as well as persistent pain, diarrhea, and nausea/vomiting ([@ref-8]). Furthermore, body weight loss reduce tolerance to treatment. Aoyama et al. found that body weight loss after gastrectomy in GC patients was an independent risk factor for the continuation of S-1 adjuvant chemotherapy ([@ref-7]). Therefore, considering the high prevalence of weight loss and its negative effect on outcome, it is necessary to identify the factors contributing to postoperative body weight change to improve the outcome and quality of life of the patients.

Body weight change in GC patents after gastrectomy involves tumor-, treatment-, and nutrition- related factors. Identifying and predicting patients at risk of postoperative body weight loss are limited. [@ref-9] analyzed factors contributing to postoperative weight loss, and found that the extend of weight loss after gastric cancer at one year depended on preoperative body mass index (BMI) and extent of gastric resection. [@ref-19] detected that grade 2 or higher post-operative complication according to Clavien-Dindo classification and total gastrectomy were significant risk factors for severe body weight loss (more than 10% body weight loss) during the first month after surgery. [@ref-21] found that higher preoperative BMI, total gastrectomy, and female sex were independent predictors of greater body weight loss at the first one year mark after gastrectomy. These studies have focused on the demographics, clinicopathology as well as treatment related factors on body weight loss, but some findings of these studies were inconsistent. Besides, patient's nutrition knowledge, attitude, and practice as internal impetus, were an important part of nutrition therapy. Patients with higher nutrition literacy would take active actions in dietary intake, which may result in body weight change. Furthermore, most of the studies on the factors affecting patient's body weight after gastrectomy were based on the measured body weight value at a certain time or the difference between the two measured values, and the analysis was inclined to a fixed time point. There is currently no multi time-point measurement to analyze the factors contributing to body weight change at multiple time points after gastrectomy in GC patients.

Hence, this study aimed to prospectively explore the influence of preoperative BMI, patient's knowledge, brief, practice score, demographics, clinicopathology, and treatment related factors on body weight change during three months after gastrectomy in patients with GC.

Material and Methods
====================

Study design
------------

Prospective longitudinal experimental design was used to identify factors contributing to body weight change during three months after gastrectomy in GC patients. Ethics approval of this study was obtained from Ruijin Hospital Ethics Committee, Shanghai Jiao Tong University School of Medicine (Shanghai, China).

Participant recruitment
-----------------------

GC Patients undergoing gastrectomy between January to March 2019 were identified in gastrointestinal surgery department prospectively. Volunteers meeting the following criteria were recruited: (1) diagnosed with GC; (2) scheduled for open gastrectomy; (3) aged 18 or above; (4) informed and agreed to participate in this study. Participates were excluded when they met condition below: (1) combined with other malignancies besides GC except distant metastasis; (2) palliative treatment; (3) recurrence within residual stomach; (4) patients with tube feeding after discharge. A written informed consent was obtained from all patients enrolled in the study. The sample size was estimated by G\*power software (version 3.1) with three repeated measures, within factors design, a power of 0.80, significant level of 0.05, and effect size of 0.30.A sample size of 43 was required for analyzing body weight change during three months after gastrectomy by considering the attrition rate of 10%.

Data collection
---------------

Volunteers were asked to complete a demographic questionnaire and a Digestive Cancer Patients Nutrition Knowledge, Attitude and Practice Questionnaire (DCNKAPQ). DCNKAPQ was designed to assess digestive cancer patients' nutrition knowledge, nutrition attitude, and nutrition practice with Cronbach's alpha 0.822 ([@ref-13]). Specifically, nutrition knowledge dimension contains 17 questions, one point would be taken when the question was given the right answer, otherwise 0. Nutrition attitude dimension includes 5 items, which are scored on a 0-4 response scale, with answers ranging from "strongly disagree" to "strongly agree". Nutrition practice dimension covers 8 items, which are scored on a 0-4 response scale, with answers ranging from "never" to "always". Total scores of DCNKAPQ range from 0 to 69, with score 0-17 from nutrition knowledge, score 0-20 from nutrition attitude, and 0-32 from nutrition practice. The demographic information included age, height, body weight, gender, marriage status, educational level, and religious faith.

Data related with disease and treatment variables were collected from electronic patient record, including cancer stage, cancer treatment, postoperative complication, nutrition support at home, and comorbidity. The tumor staging was evaluated using the 7th edition tumor-node-metastasis (TNM). The Charlson comorbidity index (CCI) was applied to represent patient's comorbidity severity. Categories of preoperative BMI were based on Asian standards proposed by WHO obesity expert advisory group in 2002, where BMI \< 18.5 kg/m^2^, BMI between 18.5 kg/m^2^ to 22.99 kg/m^2^, BMI between 23 kg/m^2^ to 24.99 kg/m^2^, and BMI ≥ 25 kg/m^2^ indicate underweight, normal weight, overweight, and obesity, respectively. Body weight were collected at admission (T0), one month (T1), two month (T2), and three month (T3) after surgery. The body weight at four time points were reported by the patient self. The patients were required to wear the same outfit without accessories every time they measured the body weight for technical consistency. The percentage of body weight loss at each point was defined as follows: (preoperative body weight --body weight at each point after surgery) \*100% / preoperative body weight.

Statistical analysis
--------------------

Data analyses were performed by IBM SPSS 20.0. Measurement data meeting normal distribution were expressed as mean ± standard deviation (SD), otherwise median combined with 25% quartiles and 75% quartiles. Categorical data were showed in the form of frequency or percentage. Generalized estimating equations (GEEs) were used to analyze the univariate and multivariable influence of demographic variables and clinical variables on body weight change in GC patients over time. Variables with at least a significant of *P* value less than 0.1 on univariate analysis (all characteristic, disease-, treatment-, nutritional variables) went on to be included in multivariate analysis. Quasi-likelihood under the independence model criterion (QIC) value is an index to evaluate whether working correlation matrix is appropriate for GEE. The lower the QIC value is, the fitter the GEE parameter estimation is. All statistics were based on two-sided test with level of significance set at 0.05.

Results
=======

Baseline characteristics of the study population
------------------------------------------------

Eighty-two potentially eligible patients were available, but 27 patients did not meet the eligibility criteria, and 6 patients did not participate in follow up from T1 to T3. A total of 49 patients were involved in the study, including 1 patient lost at T1, but recovered at T2 and T3. There was no case of relapse observed during the follow-up period. The median age of them was 57 years old (range 29-75 years old), the median preoperative body weight of male was 69.25 (62.50, 72.50) kg in male GC patients and 57.00 (51.00, 61.00) kg in female GC patients. The majority of them were married (91.80%), without specific religious faith (85.71%), and with a stage III or IV cancer (95.92%). There were 13 cases with postoperative complications, including 6 cases with infection, 3 cases with delayed gastric empty, 1 case with diarrhea, 1 with bleeding, 1 with duodenal stump fistula, and 1 with deep vein thrombosis. The median value of CCI, nutrition knowledge, attitude, and practice score were 5.00 (3.00, 6.00) points, 12.00 (8.00, 13.00) points,15.00 (14.00, 18.00) points, and 21.00 (18.00, 23.00) points, respectively. Most of them were treated with neoadjuvant chemotherapy combined with gastrectomy (81.63%), where the chemotherapy was mainly based on paclitaxel (75.00%). Around half of the subjects underwent subtotal gastrectomy (51.02%). After discharge, 57.14% patients took oral nutrition supplements (ONS) during the follow up ([Tables 1](#table-1){ref-type="table"} and [2](#table-2){ref-type="table"})

Body weight change before and during three months after gastrectomy
-------------------------------------------------------------------

The median body weight loss in GC patient at T1, T2, and T3 was 9.85% (7.41%, 11.76%), 12.14% (8.70%, 12.14%), and 11.63% (8.51%, 14.40%), respectively, for the whole cohort ([Fig. 1](#fig-1){ref-type="fig"}). The GEE results showed a significant effect of time (Wald *χ*^2^ = 333.917, *P* \< 0.001), indicating a decrease in body weight over time. According to the GEE parameter estimation, patient's body weight decreased by 9.2% at T1 (Wald *χ*^2^ = 271.173, *P* \< 0.001), 11.0% at T2 (Wald *χ*^2^ = 277.267, *P* \< 0.001), and 11.4% at T3 compared to baseline at T0 (Wald *χ*^2^ = 284.076, *P* \< 0.001) ([Table 3](#table-3){ref-type="table"}).

Factors contributed to body weight change during three months after gastrectomy
-------------------------------------------------------------------------------

Each study variable entered GEE separately for univariate analysis. The results of the GEEs for univariate analysis showed that total gastrectomy patients had greater body weight loss compared with distal gastrectomy patients (β = 3.1%, *P* = 0.003), patients with postoperative complication was associated with greater body weight loss than patients without postoperative complication (β = 3.0%, *P* = 0.010), BMI ≥ 25 kg/m^2^ was associated with greater body weight loss compared with BMI \< 18.5 kg/m^2^ (β = 3.9%, *P* = 0.080), and higher nutrition practice score was associated with greater weight loss (β = 0.3%, *P* = 0.070) ([Table 4](#table-4){ref-type="table"}). Therefore, those variables with *P* value less than 0.1 (operation type, preoperative BMI, post-operative complication, and nutrition practice score) were entered into GEE to do multivariable analysis. The results of GEE multivariable analysis indicated that surgery type and preoperative BMI were contributing factors of body weight change, while other variables, including postoperative complication and nutrition practice were not relevant. Compared with distal gastrectomy patients, total gastrectomy patients experienced greater body weight loss (β = 2.8%, *P* = 0.014). Compared with patient with BMI\<18.5 kg/m^2^, patients with BMI ≥ 25 kg/m^2^ experienced greater body weight loss (β = 4.5% *P* = 0.026) ([Table 5](#table-5){ref-type="table"}).
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###### Demographic, clinicopathology, treatment characteristics of patients with GC.
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  Variables                           N (percentage)
  ----------------------------------- ----------------
  **Age**                             
  \<65 y                              37 (75.51%)
  ≥65 y                               12 (24.49%)
  **Gender**                          
  Male                                22 (44.90%)
  Female                              27 (55.10%)
  **Marriage status**                 
  Single                              1 (2.04%)
  Married                             45 (91.84%)
  Devoiced or widowed                 3 (6.12%)
  **Education level**                 
  Elementary or below                 9 (18.37%)
  Middle                              8 (16.33%)
  High                                11 (22.45%)
  College or above                    21 (42.86%)
  **Religion**                        
  None                                42 (85.71%)
  Buddhism                            7 (14.29%)
  **Preoperative BMI**                
  Underweight                         5 (10.20%)
  Normal weight                       21 (42.86%)
  Overweight                          10 (20.41%)
  Obesity                             13 (26.53%)
  **Cancer stage**                    
  II                                  2 (4.08%)
  III                                 28 (57.14%)
  IV                                  19 (38.78%)
  **Cancer therapy**                  
  Surgery                             1 (2.04%)
  Surgery + Chemotherapy              8 (16.33%)
  Neoadjuvant chemotherapy +Surgery   40 (81.63%)
  **Type of operation**               
  Distal                              25 (51.02%)
  Total                               24 (48.98%)
  **Type of chemotherapy**            
  Base on paclitaxel                  37 (75.51%)
  Base on xeloda                      1 (2.04%)
  Base on oxaliplatin                 4 (8.16%)
  Base on irinotecan                  1 (2.04%)
  Base on S-1                         6 (12.24%)
  **ONS**                             
  Without                             28 (57.14%)
  With                                21 (42.86%)
  **Complication**                    
  Without                             36 (73.47%)
  With                                13 (26.53%)

**Notes.**

BMIbody mass indexONSoral nutritional supplements

Discussion
==========

Body weight change after gastrectomy
------------------------------------

GC Patients often experience body weight loss after gastrectomy, which involves complicated mechanism and a lot of factors, including remnant stomach, malabsorption, hormonal changes, and life style ([@ref-3]). Some scholars deemed that subtotal or total excision of gastric tissue negatively influence digestion and absorption of food inevitably. Also, operation itself may result in anorexia, thereby leading to body weight loss ([@ref-14]). [@ref-11] found that postoperative body weight loss and anemia might originate from altered absorptive function and metabolic change after gastrectomy rather than decreased nutrient intake. [@ref-4] revealed that mean body weight loss at 1 month reached 3.4 kg (5.90% of body weight) compared with preoperative mean body weight in Japanese subjects . The team of Aoyama et al. also found that mean body weight loss value at 1 month and 3 months after surgery were 6.5% and 9.0% respectively in the elderly, while 6.0% and 8.1% respectively in the non-elderly from the preoperative value, but the difference of weight loss over time between elderly and non-elderly was not significant ([@ref-5]). In China, researchers found that mean body weight loss up to 5.8--8.8 kg at 1 month ([@ref-20]), and 6.33 kg at 3 months ([@ref-22]) after gastrectomy compared with preoperative body weight. Our results show that the percentage of body weight loss up reached 9.2% (5.67 kg) at 1 month, 11.0% (6.83 kg) at 2 months, and 11.4% (7.14 kg) at 3 months after surgery from preoperative mean body weight. The higher body weight loss at three months in our study is possibly related the fact that most of the enrolled patients were advanced staged and underwent extensive chemotherapy.
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###### CCI and KAP characteristics of patients with GC.
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  Variables               Median   25% quartiles, 75% quartiles
  ----------- ----------- -------- ------------------------------
  CCI                     5.00     3.00, 6.00
  KAP         Knowledge   12.00    8.00, 13.00
              Attitude    15.00    14.00, 18.00
              Practice    21.00    18.00, 23.00

**Notes.**

CCICharlson comorbidity indexKAPNutrition Knowledge, Attitude and Practice

![The loss of body weight after gastrectomy at T1, T2, and T3 in this study.\
T0: before surgery, T1: 1 month after gastrectomy, T2: 2 months after gastrectomy, T3: 3 months after gastrectomy, Bars: Median, boxes: lower and upper quartiles, lines: minimum and maximum.](peerj-08-9390-g001){#fig-1}
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###### Percentage of body weight change over time before and during 3 months after gastrectomy in GC patients.
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  Variables   β       SE     95% CI   Wald *χ*2   P         
  ----------- ------- ------ -------- ----------- --------- ---------
  Time                                            333.917   \<0.001
  T3          11.4%   6.8%   10.1%    12.8%       284.076   \<0.001
  T2          11.0%   6.6%   9.7%     12.3%       277.267   \<0.001
  T1          9.2%    5.6%   8.1%     10.3%       271.173   \<0.001
  T0          ---                                           

**Notes.**

T0before surgeryT11 month after gastrectomyT22 months after gastrectomyT33 months after gastrectomyBMIbody mass indexβpartial regression coefficientSEstandard errorCIconfidence interval
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###### Association of study variables with body weight change three months after gastrectomy in univariate analysis.
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  Variables                            β        SE      95%CI    Wald *χ*^2^   *P*     
  ------------------------------------ -------- ------- -------- ------------- ------- -------
  **Age**                                                                              
  \<65 y                               1.4%     1.4%    --1.3%   4.2%          1.071   0.301
  ≥65 y                                ---                                             
  **Gender**                                                                           
  Female                               \<0.1%   1.1%    --2.2%   2.3%          0.001   0.977
  Male                                 ---                                             
  **Marriage status**                                                                  
  Single, or devoiced or widowed       --1.7%   2.5%    --6.5%   3.1%          0.472   0.492
  Married                              ---                                             
  **Education level**                                                          2.275   0.321
  Middle or below                      1.9%     12.8%   --0.6%   4.4%          2.197   0.138
  High                                 1.4%     1.5%    --1.5%   4.3%          0.847   0.358
  College or above                     ---                                             
  **Religion**                                                                         
  Buddhism                             2.0%     1.6%    --1.0%   5.0%          1.645   0.200
  No religion                          ---                                             
  **Cancer stage**                                                             1.514   0.469
  IV                                   3.3%     3.1%    --2.7%   9.4%          1.158   0.282
  III                                  2.2%     3.0%    --3.6%   8.1%          0.550   0.458
  II                                   ---                                             
  **Type of operation**                                                                
  Total                                3.1%     1.1%    1.0%     5.2%          8.551   0.003
  Distal                               ---                                             
  **Treatment type**                                                           0.585   0.747
  Surgery                              0.4%     0.7%    --0.8%   1.7%          0.442   0.506
  Surgery + Chemotherapy               --0.1%   1.7%    --3.4%   3.1%          0.008   0.929
  Neoadjuvant chemotherapy + Surgery   ---                                             
  **ONS**                                                                              
  With                                 0.9%     1.1%    --1.3%   3.2%          0.667   0.414
  Without                              ---                                             
  **Preoperative BMI**                                                         8.993   0.029
  Obesity                              3.9%     2.2%    --0.5%   8.2%          3.063   0.080
  Overweight                           0.8%     2.5%    --4.1%   --5.7%        0.092   0.761
  Normal weight                        1.6%     2.3%    --3.0%   --6.1%        0.456   0.499
  Underweight                          ---                                             
  **Complication**                                                                     
  With                                 3.0%     1.1%    0.7%     5.2%          6.700   0.010
  Without                              ---                                             
  CCI                                  0.2%     0.2%    --0.2%   0.6%          0.878   0.349
  Knowledge                            0.1%     0.1%    --0.2%   0.3%          0.260   0.610
  Attitude                             0.3%     0.2%    --0.1%   0.6%          2.012   0.156
  Practice                             0.3%     0.2%    \<0.1%   0.6%          3.288   0.070

**Notes.**

ONSoral nutritional supplementsBMIbody mass indexCCICharlson comorbidity indexβpartial regression coefficientSEstandard errorCIconfidence interval
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###### Association of study variables with body weight change three months after gastrectomy in multivariable analysis.

![](peerj-08-9390-g006)

  Variables           β        SE       95% CI   Wald *χ*^2^   *P*      
  ------------------- -------- -------- -------- ------------- -------- ---------
  Intercept           11.2%    2.9%     5.5%     7.0%          14.624   \<0.001
  Time                                                         19.780   \<0.001
  T1                  --0.2%   0\. 5%   --3.2%   --1.2%        19.438   \<0.001
  T2                  --0.4%   0\. 3%   --1.0%   0.2%          1.999    0.157
  T3                  ---                                               
  Preoperative BMI                                             12.662   0.005
  Obesity             4.5%     2.1%     0\. 5%   8.4%          4.928    0.026
  Overweight          1.9%     2.3%     --2.6%   6.3%          0.673    0.412
  Normal weight       1.3%     2.0%     --2.6%   5.3%          0.430    0.512
  Underweight         ---                                               
  Type of operation                                                     
  Total               2.8%     1.2%     0.6%     5.1%          6.027    0.014
  Distal              ---                                               
  Complication                                                          
  With                1.0%     1.3%     --1.6%   3.6%          0.533    0.465
  Without             ---                                               
  Practice            0.2%     0.1%     \<0.1%   0.5%          3.010    0.083

**Notes.**

T11 month after gastrectomyT22 months after gastrectomyT33 months after gastrectomyBMIbody mass indexβpartial regression coefficientSEstandard errorCIconfidence interval

The variation of postoperative body weight loss in different studies indicated that postoperative body weight was affected by a lot of factors. [@ref-4] found that body weight loss during the first week after surgery was significantly greater than that during subsequent 3 weeks, and loss of lean body mass accounted for a significant part of body weight loss during the first week due to surgical stress . [@ref-1] discovered that both fat and muscle mass reduction accounted for body weight loss during the first month after gastrectomy, and fat mass loss followed was responsible for weight loss after that period . Therefore, since energy deficiency and fat mass consumption rather than protein consumption are more prominent after discharge, continuous oral intake and exercise intervention should be given to GC patients after discharge to ensure the sufficient energy intake. In addition, body weight loss at 2 months was not significantly different from at 3 months after gastrectomy in this study, indicating that clinician should pay attention to the underlying causes of weight loss and direct nutrition intervention before 2 months after gastrectomy as soon as possible.

Factors contributed to body weight change after gastrectomy
-----------------------------------------------------------

The results of GEE showed significant main effect of preoperative BMI categories on body weight change after gastrectomy. Same as the findings in previous study ([@ref-5]; [@ref-20]; ([@ref-22])), we found that the percentage of body weight loss showed a downward trend as a whole within 3 months after gastrectomy, and the percentage of body weight loss within the first month postoperative period was significantly more than that in the third month postoperative. Similar to the findings in the study of Tanabe et al. who found that higher preoperative BMI, was independent predictors of greater body weight loss at the first one year mark after gastrectomy ([@ref-21]). We found that BMI ≥ 25 kg/m^2^ was risk factors to body weight loss during three months after gastrectomy in GC patients. However, the result was contract with the study by [@ref-18] who found that preoperative BMI \< 23 kg/m ^2^were associated with severe weight loss after gastrectomy . Similar to previous studies ([@ref-9]; [@ref-16]; [@ref-19]), we found that total gastrectomy was a risk factor for postoperative weight loss. Previous study observed that decreased calorie intake after total gastrectomy compared with distal gastrectomy ([@ref-17]), which may explain total gastrectomy patients experienced more body weight loss.

Similar to the findings in the study of [@ref-9], we found that postoperative complication was not found to be independent factor on postoperative body weight loss in this study. While Segami et al. found that surgical complication was a significant risk factor for severe body weight loss the first month after gastrectomy ([@ref-19]). The conflict results prompt the complexity of weight loss in GC patients after gastrectomy. As for higher nutrition knowledge, attitude, and practice score were positively related with higher self-efficacy ([@ref-13]), which is a vital theory to implement nutrition education, less weight loss was expected to appear in patients with higher nutrition knowledge, attitude, and practice score in this study. However, there was no significant effect of nutrition knowledge, attitude, and practice on postoperative body weight loss. Consistent with some scholars' findings ([@ref-5]; [@ref-9]), our study verified that age was not a risk factor for postoperative body weight loss during 3 months after gastrectomy. Recently, Aoyama et al. found that postoperative lean body mass decreased significantly in elderly compared with non-elderly rather than body weight ([@ref-5]).

There were some limitations in this study. Firstly, this was a single center study, 95.92% patients involved in our study were with cancer stage III or IV GC. So, the results that total gastrectomy and preoperative BMI were factors contributing to body weight change may not generalizable to patients with stage I or II. Secondly, we did not collect data about patient nutritional intake amount during 3 months after gastrectomy. So, the nutrition therapy factors on body weight change may be ignored in our study. Thirdly, the body weight at each point was reported by the patient self.

Conclusion
==========

GC patients experienced significant body weight loss during three months after gastrectomy. Total gastrectomy and BMI ≥ 25 kg/m^2^ were risk factors to postoperative body weight loss for GC patients in this study. Given adverse effect of weight loss after surgery on overall survival and quality of life, the results suggested hinted that clinician should pay attention to postoperative nutrition status of GC patient undergoing total gastrectomy and obesity patients.
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